Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1,251–1,275 of 7,816 matching trials · page 51 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Prognosis of Depression in the Elderly (PRODE). A Multicentre, Longitudinal Study of Elderly Depressed Patients. NCT01952366 Runs in: Norway · 1 site |
NA other |
COMPLETED | 169 | Sykehuset Innlandet HF OTHER |
2026-04-13 |
|
Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression NCT02959502 Receive tDCS+CR; Facilitate tDCS + CR Runs in: Canada · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 40 | Centre for Addiction and Mental Health OTHER |
2026-04-13 |
|
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia NCT03672201 Non-Pharmacological Intervention; Pharmacological Intervention Runs in: Canada · 6 sites |
NA other |
ACTIVE_NOT_RECRUITING | 187 | Centre for Addiction and Mental Health OTHER |
2026-04-13 |
|
Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS NCT03846492 Transcranial Direct Current Stimulation (tDCS) Runs in: Canada · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 90 | Centre for Addiction and Mental Health OTHER |
2026-04-13 |
|
Enhancement of Hippocampal Plasticity Using Repetitive Transcranial Magnetic Stimulation NCT03962959 TBS Runs in: United States · 1 site |
NA other |
COMPLETED | 97 | University of Arizona OTHER |
2026-04-13 |
|
Prevalence and Level of Diagnosis of Dementia in a Population-based Sample in the County of Trøndelag NCT04289389 Runs in: Norway · 1 site |
NA other |
COMPLETED | 11,675 | Norwegian Centre for Ageing and Health OTHER |
2026-04-13 |
|
Exercise as a Primer for Brain Stimulation in Vascular Cognitive Impairment No Dementia (VCIND) NCT05079464 tDCS; Exercise; Sham stimulation; Treatment as usual Runs in: Canada · 1 site |
NA other |
RECRUITING | 64 | Sunnybrook Health Sciences Centre OTHER |
2026-04-13 |
|
rTMS for Apathy Clinical Trial NCT05561205 rTMS; methylphenidate Runs in: Canada · 1 site |
NA other |
RECRUITING | 10 | Sunnybrook Health Sciences Centre OTHER |
2026-04-13 |
|
Cognitive Neurology Unit Clinical Registry NCT05925621 Lecanemab Runs in: United States · 1 site |
NA anti-amyloid-antibody |
RECRUITING | 500 | Beth Israel Deaconess Medical Center OTHER |
2026-04-13 |
|
Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD) NCT06160908 NirsCure; sham NirsCure; NirsCure Runs in: China · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 38 | Xuanwu Hospital, Beijing OTHER |
2026-04-13 |
|
Effects of Jing Si Herbal Tea on Quality of Life and Sleep in Dementia and Their Caregivers NCT06198699 Jing Si Herbal Tea Runs in: Taiwan · 1 site |
NA other |
RECRUITING | 400 | National Cheng Kung University OTHER |
2026-04-13 |
|
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce NCT06239688 essentiALZ; Project ECHO Runs in: United States · 1 site |
NA other |
RECRUITING | 1,764 | University of North Carolina, Chapel Hill OTHER |
2026-04-13 |
|
Prioritising Patient Medication Review: Hospitals Reaching Out NCT06451692 Clinical pharmacist Runs in: Denmark · 1 site |
NA other |
RECRUITING | 800 | University of Southern Denmark OTHER |
2026-04-13 |
|
Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG NCT06501495 video polysomnography; Attention task Runs in: France · 1 site |
NA other |
RECRUITING | 90 | Assistance Publique - Hôpitaux de Paris OTHER |
2026-04-13 |
|
TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI) NCT06783283 Transcranial Alternating Current Stimulation; Sham tACS Runs in: Canada · 1 site |
NA other |
RECRUITING | 20 | Centre for Addiction and Mental Health OTHER |
2026-04-13 |
|
VR Hand Exercises: Impact on Cognition and Dexterity in MCI NCT07005271 virtual reality; Conventional treatment Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 29 | Istinye University OTHER |
2026-04-13 |
|
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol NCT07012993 18F-Florbetapir or 18F-Flutemetamol Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 200 | Akiva Mintz OTHER |
2026-04-13 |
|
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease NCT07451613 hNSC-01 Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 21 | Leslie Thompson OTHER |
2026-04-13 |
|
DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community NCT07521722 Runs in: Spain · 1 site |
NA other |
NOT_YET_RECRUITING | 250 | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation OTHER |
2026-04-13 |
|
Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD) NCT02386670 tDCS + CR; sham tDCS + sham CR Runs in: Canada · 5 sites |
NA other |
ACTIVE_NOT_RECRUITING | 375 | Centre for Addiction and Mental Health OTHER |
2026-04-09 |
|
Epidemiological Study in FRONtoTemporal Dementia NCT05075187 Genetic Screening Runs in: Belgium; Germany; Greece; Italy; Portugal; Spain; Turkey ... · 37 sites |
NA other |
COMPLETED | 2,287 | CENTOGENE GmbH Rostock INDUSTRY |
2026-04-09 |
|
A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease. NCT06185543 PrimeC; Placebo Runs in: Israel · 1 site |
PHASE2 other |
TERMINATED | 8 | NeuroSense Therapeutics Ltd. INDUSTRY |
2026-04-09 |
|
Cholinergic Enhancement of Theta NCT07228338 COBENFY KarXT (50/20 mg); Placebo Runs in: United States · 1 site |
EARLY_PHASE1 other |
NOT_YET_RECRUITING | 50 | University of Texas Southwestern Medical Center OTHER |
2026-04-09 |
|
Creative Drama on Gender Role Stress, Attitudes Toward Violence Against Women, and Aggression NCT07241156 Creative Drama Program; Film Viewing Sessions |
NA other |
NOT_YET_RECRUITING | 75 | Ataturk University OTHER |
2026-04-09 |
|
The Underlying Neural Mechanism of TMS in Improving the Imbalance of "Microbiota-brain-gut Axis" in Alzheimer 's Disease Population NCT07346794 TMS |
NA other |
NOT_YET_RECRUITING | 400 | Second Affiliated Hospital of Nanchang University OTHER |
2026-04-09 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial